The forecasted data for pancreas malignant neoplasms mortality in the UK indicates an upward trend from 2024 to 2028, with deaths increasing from 10.58 thousand to 11.19 thousand. In 2023, the actual recorded deaths were lower than 10.58 thousand. Year-on-year variations highlight a steady increase, reflecting an annual growth rate. The compound annual growth rate (CAGR) shows a consistent rise, projecting significant health challenges ahead.

Future trends to monitor include:

Advancements in early detection and treatment for pancreatic cancer.
Public health policies aimed at addressing risk factors such as smoking, obesity, and diabetes.
Investment in healthcare infrastructure to manage the rising mortality rates.